全文获取类型
收费全文 | 2409篇 |
免费 | 173篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 85篇 |
妇产科学 | 66篇 |
基础医学 | 278篇 |
口腔科学 | 46篇 |
临床医学 | 274篇 |
内科学 | 516篇 |
皮肤病学 | 80篇 |
神经病学 | 155篇 |
特种医学 | 52篇 |
外科学 | 272篇 |
综合类 | 12篇 |
预防医学 | 221篇 |
眼科学 | 49篇 |
药学 | 158篇 |
中国医学 | 26篇 |
肿瘤学 | 289篇 |
出版年
2023年 | 31篇 |
2022年 | 58篇 |
2021年 | 170篇 |
2020年 | 75篇 |
2019年 | 146篇 |
2018年 | 131篇 |
2017年 | 85篇 |
2016年 | 88篇 |
2015年 | 82篇 |
2014年 | 120篇 |
2013年 | 111篇 |
2012年 | 170篇 |
2011年 | 170篇 |
2010年 | 107篇 |
2009年 | 77篇 |
2008年 | 125篇 |
2007年 | 108篇 |
2006年 | 100篇 |
2005年 | 94篇 |
2004年 | 80篇 |
2003年 | 86篇 |
2002年 | 86篇 |
2001年 | 33篇 |
2000年 | 41篇 |
1999年 | 28篇 |
1998年 | 12篇 |
1997年 | 18篇 |
1996年 | 10篇 |
1995年 | 10篇 |
1994年 | 9篇 |
1993年 | 4篇 |
1992年 | 14篇 |
1991年 | 11篇 |
1990年 | 16篇 |
1989年 | 14篇 |
1988年 | 6篇 |
1987年 | 14篇 |
1986年 | 6篇 |
1985年 | 4篇 |
1984年 | 5篇 |
1982年 | 5篇 |
1981年 | 4篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1977年 | 3篇 |
1976年 | 4篇 |
1972年 | 2篇 |
1969年 | 2篇 |
1966年 | 2篇 |
1965年 | 2篇 |
排序方式: 共有2599条查询结果,搜索用时 62 毫秒
31.
Setor K. Kunutsor Michael R. Whitehouse Ashley W. Blom Tim Board Peter Kay B. Mike Wroblewski Valérie Zeller Szu-Yuan Chen Pang-Hsin Hsieh Bassam A. Masri Amir Herman Jean-Yves Jenny Ran Schwarzkopf John-Paul Whittaker Ben Burston Ronald Huang Camilo Restrepo Javad Parvizi Sergio Rudelli Emerson Honda David E. Uip Guillem Bori Ernesto Muñoz-Mahamud Elizabeth Darley Alba Ribera Elena Cañas Javier Cabo José Cordero-Ampuero Maria Luisa Sorlí Redó Simon Strange Erik Lenguerrand Rachael Gooberman-Hill Jason Webb Alasdair MacGowan Paul Dieppe Matthew Wilson Andrew D. Beswick The Global Infection Orthopaedic Management Collaboration 《European journal of epidemiology》2018,33(10):933-946
One-stage and two-stage revision strategies are the two main options for treating established chronic peri-prosthetic joint infection (PJI) of the hip; however, there is uncertainty regarding which is the best treatment option. We aimed to compare the risk of re-infection between the two revision strategies using pooled individual participant data (IPD). Observational cohort studies with PJI of the hip treated exclusively by one- or two-stage revision and reporting re-infection outcomes were retrieved by searching MEDLINE, EMBASE, Web of Science, The Cochrane Library, and the WHO International Clinical Trials Registry Platform; as well as email contact with investigators. We analysed IPD of 1856 participants with PJI of the hip from 44 cohorts across four continents. The primary outcome was re-infection (recurrence of infection by the same organism(s) and/or re-infection with a new organism(s)). Hazard ratios (HRs) for re-infection were calculated using Cox proportional frailty hazards models. After a median follow-up of 3.7 years, 222 re-infections were recorded. Re-infection rates per 1000 person-years of follow-up were 16.8 (95% CI 13.6–20.7) and 32.3 (95% CI 27.3–38.3) for one-stage and two-stage strategies respectively. The age- and sex-adjusted HR of re-infection for two-stage revision was 1.70 (0.58–5.00) when compared with one-stage revision. The association remained consistently absent after further adjustment for potential confounders. The HRs did not vary importantly in clinically relevant subgroups. Analysis of pooled individual patient data suggest that a one-stage revision strategy may be as effective as a two-stage revision strategy in treating PJI of the hip. 相似文献
32.
33.
Analia Rodríguez Garzotto C. Vanesa Díaz-García Alba Agudo-López Elena Prieto García Santiago Ponce José A. López-Martín Luis Paz-Ares Lara Iglesias M. Teresa Agulló-Ortuño 《Medical oncology (Northwood, London, England)》2016,33(10):105
Tumor angiogenesis pathways have been identified as important therapeutic targets in non-small cell lung cancer. However, no biomarkers have been described as predictors of response to antiangiogenic therapy in these patients. In this study, plasma levels of VEGF, bFGF, E-selectin, and S-ICAM and gene expression profiles of peripheral blood mononuclear cells from non-small cell lung cancer patients treated with chemotherapy plus bevacizumab were analyzed before and after treatment. Values were correlated with clinicopathological characteristics and treatment response. Plasma factor levels were measured using commercially available ELISA kits. The TaqMan® human angiogenesis array was used to investigate the effect of treatment on gene expression profiles. Kyoto Encyclopedia of Genes and Genomes and Gene Ontology enrichment analysis was performed for differentially expressed genes using WEB-based GEne SeT AnaLysis Toolkit. Our results suggest a benefit for patients with increased plasma levels of VEGF, E-selectin, and S-ICAM in the course of bevacizumab treatment. Also, we identified differentially expressed genes between paired blood samples from patients before and after treatment, and significantly perturbed pathways were predicted. These changes in gene expression and levels of plasma factors could be used to assess the effectiveness of antiangiogenic therapy, in addition to standard clinical and radiological evaluations. 相似文献
34.
Sarah Heili Frades María del Pilar Carballosa de Miguel Alba Naya Prieto Marina Galdeano Lozano Xavier Mate García Ignacio Mahillo Fernández Itziar Fernández Ormaechea Laura Álvarez Suárez Farah Ezzine de Blas María José Checa Venegas Nicolás González Mangado Germán Peces Barba 《Archivos de bronconeumologia》2019,55(12):634-641
IntroductionHistorically, it has been assumed that Intermediate Respiratory Care Units (IRCU) were efficient, because they saved costs by reducing the number of admissions to intensive care units (ICU), and effective, because they specialized in respiratory diseases.MethodsThe number of IRCU admissions and mortality rate, historically and in 2016, were evaluated. For 2016, the grouped Related Diagnostic Groups (DRGs) were also described, and the savings achieved under all budgetary headings by avoiding UCI stays were calculated. A multivariate analysis was performed to associate costs with mean weights and complexity, and multiple logistic regression was performed on all patients admitted from 2004 to 2017 to describe the variables associated with mortality in our unit.ResultsAn IRCU generates savings of €500,000/year by reducing length of ICU stay. Analysis of the 2016 cohort shows that costs correlate with mean weight and mortality, and consequently complexity. The multivariate logistic regression analysis of the 2004–2017 cohort found respiratory frequency, leukopenia, anemia, hyperkalemia, and acidosis to be the variables best associated with mortality. The area under the curve for the logistic model was 0.75.ConclusionThe IRCU analyzed in our study was efficient in terms of ‘avoided costs’ and savings associated with complexity. Our results suggest that IRCUs have a lower mortality rate than other similar units, and are therefore a safe environment for patients. 相似文献
35.
36.
37.
Ximena Terra PhD Teresa Auguet MD PhD Zaida Agüera MSc Isabel Maria Quesada Josep Maria Orellana‐Gavaldà PhD Carmen Aguilar PhD Susana Jiménez‐Murcia PhD Alba Berlanga MSc Esther Guiu‐Jurado MSc José Manuel Menchón MD Fernando Fernández‐Aranda PhD Cristóbal Richart MD PhD 《The International journal of eating disorders》2013,46(8):855-861
38.
39.
40.